Clinical Trial Update: TDCS-Augmented Prolonged Exposure Therapy [NA]

View source ↗

Summary

The clinical trial evaluating TDCS-augmented prolonged exposure therapy for PTSD has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Depressive Disorders
• Posttraumatic Stress Disorder

Snippet

Sponsor: Medical University of South Carolina | Conditions: Posttraumatic Stress Disorder, PTSD | NA | Status: WITHDRAWN